Targeting of Immune Response After Pneumococcal Vaccination
NCT01402245
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Pneumococcal Pneumonia
Interventions
BIOLOGICAL:
Pneumococcal polysaccharide vaccine
BIOLOGICAL:
pneumococcal conjugate vaccine
Sponsor
Helsinki University Central Hospital